Before adding and sharing your Fraud Alert please check to see if a similar alert has already been posted, thank you:

KERX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class …

Post a Fraud Alert:

NEW YORK–(BUSINESS WIRE)–The Law Offices of Vincent Wong announce that a class action lawsuit has
been commenced in the USDC for the Southern District of New York on
behalf of investors who purchased Keryx Biopharmaceuticals, Inc. (NASDAQ:
KERX) securities February 25, 2016 and August 1, 2016.

Click here to learn about the case:
There is no cost or obligation to you.

According to the complaint, throughout the Class Period, Defendants made
materially false and/or misleading statements, as well as failed to
disclose material adverse facts about the Company’s business,
operations, and prospects. Specifically, Defendants made false and/or
misleading statements and/or failed to disclose: (1) that the Company
was experiencing production-related difficulties in converting API to
finished drug product; (2) that the issue was resulting in decreased
production yields of finished drug product; (3) that, as a result, the
Company would, and did exhaust its reserve of finished drug product; and
(4) that, as a result of the foregoing, Defendants’ statements about
Keryx’s business, operations, and prospects, were false and misleading
and/or lacked a reasonable basis.

If you suffered a loss in Keryx Biopharmaceuticals you have until
October 3, 2016 to request that the Court appoint you as lead plaintiff.
Your ability to share in any recovery doesn’t require that you serve as
a lead plaintiff. To obtain additional information, contact Vincent
Wong, Esq. either via email,
by telephone at 212.425.1140, or visit

Vincent Wong, Esq. is an experienced attorney that has represented
investors in securities litigations involving financial fraud and
violations of shareholder rights. Attorney advertising. Prior results do
not guarantee similar outcomes.

Article source: